How has been the historical performance of Astrazeneca Phar?
In terms of assets and liabilities, total assets increased to 1,476.56 Cr in March 2025 from 1,056.78 Cr in March 2024, while total liabilities also rose to 1,476.56 Cr in March 2025 from 1,056.78 Cr in March 2024. The company maintained a strong cash position, with cash and cash equivalents rising to 536.70 Cr in March 2025 from 505.84 Cr in March 2024. The net cash inflow for March 2025 was 30.00 Cr, compared to 5.00 Cr in March 2024, indicating improved cash flow from operations. Overall, Astrazeneca Phar has demonstrated robust growth in sales and assets, despite fluctuations in profit margins and earnings per share.
Breakdown:
Astrazeneca Phar has shown a strong upward trend in net sales, which increased from 1,002.97 Cr in March 2023 to 1,716.29 Cr in March 2025. This growth in revenue has been accompanied by a rise in total operating income, which reached 1,716.29 Cr in March 2025. However, the total expenditure also increased significantly, leading to an operating profit of 294.60 Cr in March 2025, a rise from 219.25 Cr in March 2024. Despite this, profit before tax saw a decline to 156.36 Cr in March 2025, down from 219.54 Cr in the previous year, and profit after tax also decreased to 115.74 Cr. The earnings per share reflected this trend, dropping to 46.3 in March 2025 from 64.6 in March 2024. On the balance sheet, total assets grew to 1,476.56 Cr in March 2025, while total liabilities matched this figure, indicating a balanced growth in both assets and liabilities. The company maintained a healthy cash position, with cash and cash equivalents increasing to 536.70 Cr, and a net cash inflow of 30.00 Cr in March 2025 suggests improved operational cash flow.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
{{text.big_txt}}
{{text .small_txt}}
{{dashverdictresult.dashboard.stock_details.short_name}}
SEND BY EMAIL
Register now to see if the stock’s characteristics match your investment style
Subscribe now to see if the stock's characteristics match your investment style
{{dashverdictresult.dashboard.risk_return_voltality.risk_type}}, {{dashverdictresult.dashboard.risk_return_voltality.return_type}}
| {{ value[0] }} | {{ value[1] }} | {{ value[2] }} | {{ value[3] }} |
| {{ value[0] }} | {{ value[1] }} | {{ value[2] }} | {{ value[3] }} |
Create your portfolio and know how much should this stock be in your portfolio
Subscribe now to know how much you should hold in this stock
We have found 2 better stocks that you can consider
{{dashverdictresult.dashboard.return_text}}
Investors Returns (3 years) –
| Period | 6M | 1Y | 2Y | 3Y |
| {{ keyd.val }} | ||||
| {{ keyd.val }} |
Quality: {{dashverdictresult.dashboard.dotsummary.q_txt}}
Valuation: {{dashverdictresult.dashboard.dotsummary.v_txt}}
Quarterly Financial Trend: {{dashverdictresult.dashboard.dotsummary.f_txt}}
Technicals: {{dashverdictresult.dashboard.dotsummary.tech_txt}}
Stock Info:
BSE – {{dashverdictresult.dashboard.stock_details.scripcode}}/ NSE – {{dashverdictresult.dashboard.stock_details.symbol}}
Market Cap – {{dashverdictresult.dashboard.priceinfo.mcap_class}} (Rs. {{dashverdictresult.dashboard.priceinfo.mcap| number :0}} cr)
Sector – {{dashverdictresult.dashboard.stock_details.ind_name}}
52 w H/L (Rs.) – {{dashverdictresult.dashboard.priceinfo.wk_high52}}/{{dashverdictresult.dashboard.priceinfo.wk_low52}}
Average vol (6M) – {{dashverdictresult.dashboard.priceinfo.vol}}
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
